Literature DB >> 26372287

Psychiatric disorders after starting dolutegravir: report of four cases.

Farid Kheloufi1, Julie Allemand, Saadia Mokhtari, Anne Default.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26372287     DOI： 10.1097/QAD.0000000000000789

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

1.  Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants.

Authors:  Shin-Ichiro Hattori; Hironori Hayashi; Haydar Bulut; Kalapala Venkateswara Rao; Prasanth R Nyalapatla; Kazuya Hasegawa; Manabu Aoki; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Clinical correlates of depression chronicity among people living with HIV: What is the role of suicidal ideation?

Authors:  Griffin A Tyree; Florin Vaida; Sidney Zisook; William C Mathews; David J Grelotti
Journal:  J Affect Disord       Date:  2019-07-30       Impact factor: 4.839

3.  Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response.

Authors:  Anna L Stern; Rebecca N Lee; Nina Panvelker; Jiean Li; Jenna Harowitz; Kelly L Jordan-Sciutto; Cagla Akay-Espinoza
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-31       Impact factor: 4.147

4.  Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.

Authors:  Angela M Bengtson; Brian W Pence; Ellen F Eaton; Jessie K Edwards; Joseph J Eron; William C Mathews; Katie Mollan; Richard D Moore; Connall O'Cleirigh; Elvin Geng; Michael J Mugavero
Journal:  Antivir Ther       Date:  2018

5.  Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database.

Authors:  Ricky Hsu; Jennifer Fusco; Cassidy Henegar; Karam Mounzer; Michael Wohlfeiler; Vani Vannappagari; Michael Aboud; Lloyd Curtis; Gregory Fusco
Journal:  Ther Adv Drug Saf       Date:  2018-10-29

6.  Associations between Antiretroviral Drugs on Depressive Symptomatology in Homogenous Subgroups of Women with HIV.

Authors:  Dionna W Williams; Yuliang Li; Yanxun Xu; Leah H Rubin; Raha Dastgheyb; Kathryn C Fitzgerald; Pauline M Maki; Amanda B Spence; Deborah R Gustafson; Joel Milam; Anjali Sharma; Adaora A Adimora; Igho Ofotokun; Margaret A Fischl; Deborah Konkle-Parker; Kathleen M Weber
Journal:  J Neuroimmune Pharmacol       Date:  2020-01-13       Impact factor: 7.285

7.  Adverse events of raltegravir and dolutegravir.

Authors:  Luigia Elzi; Stefan Erb; Hansjakob Furrer; Matthias Cavassini; Alexandra Calmy; Pietro Vernazza; Huldrych Günthard; Enos Bernasconi; Manuel Battegay
Journal:  AIDS       Date:  2017-08-24       Impact factor: 4.177

8.  Psychiatric Disorders after Switching to Dolutegravir: A Case Report of a 59-Year-Old Virosuppressed HIV-1 Positive Woman.

Authors:  Daniele Mengato; Raffaella Binazzi; Ivan Unterholzner; Elke M Erne; Alicia Tavella
Journal:  Case Rep Infect Dis       Date:  2020-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.